Mercer Global Advisors’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Buy
8,878
+1,073
+14% +$67.6K ﹤0.01% 1916
2025
Q4
$437K Buy
7,805
+478
+7% +$27.7K ﹤0.01% 1958
2025
Q3
$461K Buy
7,327
+2,798
+62% +$166K ﹤0.01% 1799
2025
Q2
$258K Sell
4,529
-82
-2% -$4.46K ﹤0.01% 1935
2025
Q1
$258K Buy
4,611
+261
+6% +$15.6K ﹤0.01% 1837
2024
Q4
$267K Hold
4,350
﹤0.01% 1817
2024
Q3
$287K Hold
4,350
﹤0.01% 1631
2024
Q2
$291K Sell
4,350
-10
-0.2% -$681 ﹤0.01% 1590
2024
Q1
$310K Sell
4,360
-28
-0.6% -$2.1K ﹤0.01% 1546
2023
Q4
$370K Sell
4,388
-10
-0.2% -$829 ﹤0.01% 1493
2023
Q3
$378K Buy
4,398
+48
+1% +$4.43K ﹤0.01% 1397
2023
Q2
$405K Sell
4,350
-129
-3% -$12.2K ﹤0.01% 1336
2023
Q1
$424K Sell
4,479
-5,202
-54% -$478K ﹤0.01% 1293
2022
Q4
$973K Sell
9,681
-17
-0.2% -$1.55K ﹤0.01% 932
2022
Q3
$827K Hold
9,698
﹤0.01% 926
2022
Q2
$833K Hold
9,698
0.01% 923
2022
Q1
$871K Hold
9,698
0.01% 950
2021
Q4
$970K Buy
9,698
+110
+1% +$11.2K 0.01% 899
2021
Q3
$890K Hold
9,588
0.01% 916
2021
Q2
$815K Hold
9,588
0.01% 931
2021
Q1
$830K Buy
+9,588
New +$843K 0.01% 864

Other funds holding UTMD

Mercer Global Advisors's UTMD Position: Q1 2026 in Review

Mercer Global Advisors increased its Utah Medical Products (UTMD) stake by 14% in Q1 2026, buying an estimated $67.6K and bringing the position to 8,878 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #1916.

Mercer Global Advisors first reported a position in UTMD in Q1 2021 and has held it in 21 quarters since. The position peaked at $973K in Q4 2022. 119 funds tracked by Wall St. Rank hold UTMD as of Q1 2026.

  • Mercer Global Advisors held 8,878 shares of Utah Medical Products worth $550K as of Q1 2026.
  • Mercer Global Advisors bought 1,073 Utah Medical Products shares in Q1 2026, an estimated $67.6K.
  • Utah Medical Products made up ﹤0.01% of Mercer Global Advisors's portfolio in Q1 2026, its #1916 holding.
  • Mercer Global Advisors first reported a position in Utah Medical Products in Q1 2021 and has held it in 21 quarters since.
  • Mercer Global Advisors's Utah Medical Products position peaked at $973K in Q4 2022.
  • 119 funds tracked by Wall St. Rank held Utah Medical Products as of Q1 2026.

Based on Mercer Global Advisors's 13F filing for Q1 2026, filed 15 May 2026.